A.S. Fenestra

ART Advanced Research Technologies Announces Delay in the Release of Its Third Quarter Results and Receipt of Notice of Delisting From TSX Effective December 11, 2009.(Financial report)
Marketwire Canada; 11/13/2009; 1305 words; ...put in place to support ART's ongoing operations by providing...uncertainties related to the company's ability to continue as a going...Company Manual. Trading in ART's Securities will remain suspended...breast cancer. Finally, the Fenestra(R) line of molecular imaging...

ART Advanced Research Technologies Inc. Secures Up to $1.2 Million in Interim Financing in Connection With the Pursuit of Its Strategic Review Process and... ...Files a Notice of Intention Under the Bankruptcy and Insolvency Act.
Marketwire Canada; 11/2/2009; 1072 words; ...review process in view of ART's ongoing financial needs. The new financing will support ART's business continuity by providing...breast cancer. Finally, the Fenestra(R) line of molecular imaging...mammography and imaging. ART's shares are listed on the TSX...

ART Advanced Research Technologies Announces Review of Strategic Options and Downsizing.
Marketwire Canada; 10/29/2009; 1171 words; ...a restructuring the Company's operations. As part of this...operating expenses. The Company's Chairman & CEO, Sebastien Gignac...breast cancer. Finally, the Fenestra(R) line of molecular imaging...mammography and imaging. ART's shares are listed on the TSX...

ART Time Domain Technology Applications to Be Presented at the World Molecular Imaging Congress in Montreal, Canada; Presentations highlight ongoing research for ART's Optix, SoftScan, and Fenestra products.
Marketwire Canada; 9/24/2009; 1512 words; ...presentations based on ART's SoftScan(R) optical...optical imaging system, and Fenestra(R) imaging agent for...M. Jean-Jacques; S.Fortier; M. Khayat...animal imaging enhanced by Fenestra LC and meglumine diatrizoate...Renard; C. Casteleyn; S. Deleye; P. Joye...

ART Advanced Research Technologies Launches Optix MX3 Molecular Imaging System at WMIC2009; Optix MX3 offers a new benchmark for imaging performance and versatility in the preclinical phases of drug development.
Marketwire Canada; 9/23/2009; 1281 words; ...well as its SoftScan(R) and Fenestra(R) product offering, as an...art tunable laser. Using ART's proven and proprietary time...allows measurement of the light's time of arrival, Optix MX3 is...mammography and imaging. ART's shares are listed on the TSX...